Neuronetics (STIM) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -309.48% |
| Dec 31, 2025 | 90.21% |
| Sep 30, 2025 | -942.40% |
| Jun 30, 2025 | 86.49% |
| Mar 31, 2025 | -693.87% |
| Dec 31, 2024 | 113.47% |
| Sep 30, 2024 | 50.52% |
| Jun 30, 2024 | 10.75% |
| Mar 31, 2024 | 19.87% |
| Dec 31, 2023 | -64.56% |
| Sep 30, 2023 | 21.62% |
| Jun 30, 2023 | 17.16% |
| Mar 31, 2023 | 21.12% |
| Dec 31, 2022 | 4.89% |
| Sep 30, 2022 | -3.49% |
| Jun 30, 2022 | 11.95% |
| Mar 31, 2022 | 13.91% |
| Dec 31, 2021 | 5.12% |
| Sep 30, 2021 | 13.81% |
| Jun 30, 2021 | 4.39% |
| Mar 31, 2021 | -142.37% |
| Dec 31, 2020 | 2.87% |
| Sep 30, 2020 | 5.35% |
| Jun 30, 2020 | 14.61% |
| Mar 31, 2020 | 15.44% |
| Dec 31, 2019 | 7.73% |
| Sep 30, 2019 | 7.66% |
| Jun 30, 2019 | 6.64% |
| Mar 31, 2019 | 7.94% |
| Dec 31, 2018 | 2.04% |
| Sep 30, 2018 | -634.05% |